Date: August 29, 2019; Source: Karolinska Institutet; Summary: The new type of drugs for type 2 diabetes, the so-called SGLT2 inhibitors, are associated with a reduced risk of heart failure and death as well as of major cardiovascular events, a major ...
from Google Alert - health https://ift.tt/2zEy6lA
via IFTTT
0 comments:
Post a Comment